JVM Co

JVM Co Current Assets

The Current Assets of JVM Co (054950.KQ) as of Nov 4, 2026 is 34.89 B KRW. In the previous year, Current Assets was 174.11 B KRW — a change of -79.96% (lower).

Current Assets

34.89 BKRW

YoY

-79.96%

Last updated:

Current Assets of JVM Co is 2025 34.89 B KRW. Current Assets of JVM Co was 2024 174.11 B KRW. It decreases by -79.96% lower compared to the previous year.

The JVM Co Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
75.10 B KRW
Jan 1, 2019
81.38 B KRW
Jan 1, 2020
86.32 B KRW
Jan 1, 2021
98.10 B KRW
Jan 1, 2022
116.97 B KRW
Jan 1, 2023
144.85 B KRW
Jan 1, 2024
174.11 B KRW
Jan 1, 2025
34.89 B KRW
The JVM Co Current Assets history
YEARCurrent AssetsYoY
34.89 BKRW-79.96%
174.11 BKRW+20.20%
144.85 BKRW+23.84%
116.97 BKRW+19.24%
98.10 BKRW+13.64%
86.32 BKRW+6.08%
81.38 BKRW+8.35%
75.10 BKRW+14.18%
65.78 BKRW-2.88%
67.73 BKRW+23.94%
54.65 BKRW+41.39%
38.65 BKRW-51.52%
79.72 BKRW+8.59%
73.42 BKRW-25.74%
98.86 BKRW-39.80%
164.21 BKRW+21.64%
134.99 BKRW+75.90%
76.74 BKRW+26.45%
60.69 BKRW+4.63%
58.01 BKRW+213.25%
18.52 BKRW+71.77%
10.78 BKRW+39.22%
7.74 BKRW+4.40%
7.42 BKRW+33.23%
5.57 BKRW-1.56%
5.66 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

JVM Co Stock analysis

What does JVM Co do? JVM Co., Ltd. manufactures pharmacy automation systems under the brand JVM, targeting domestic and overseas markets. The company's primary products include automatic tablet dispensing and packaging systems (ATDPSs), automatic tablet classification and packing machines available in slide, box, and drum types, total safety solutions, automatic medication vision inspection systems (VIZENs), automatic package cutting and winding systems (WIZERs), and automatic medication sorting and control systems (AccuPharm). These products are sold to customers in the pharmaceutical and healthcare sectors seeking efficient automation solutions for medication handling and safety. The firm generates revenue through the sale of its branded automation systems, with a focus on domestic distribution and international markets. JVM's product portfolio addresses key operational needs in pharmacy settings, including dispensing, classification, inspection, and sorting of medications, ensuring compliance with safety standards while improving workflow efficiency. The company's offerings are designed to meet the demands of healthcare providers and pharmaceutical manufacturers requiring advanced automation technologies. JVM's business model centers on providing comprehensive automation solutions for pharmacy operations, leveraging its established brand JVM to differentiate its products in the market. By offering a wide range of specialized systems, the company caters to both domestic and international clients seeking reliable, high-quality automation equipment for medication management and safety protocols. JVM Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about JVM Co stock

Current Assets of JVM Co is 34.89 B KRW in 2025.

Current Assets of JVM Co changed from 174.11 B KRW to 34.89 B KRW, representing a -79.96% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Assets JVM Co since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's JVM Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — JVM Co

All Key Metrics — JVM Co